PCT International Application
ANTISENSE OLIGOMERS AGAINST MONOAMINE OXIDASE B AND USE THEREOF
Published Dec. 7, 2023
View on Espacenet ↗
Abstract
The present invention relates to antisense oligomers against monoamine oxidase B and a use thereof, and to: antisense oligomers that regulate the amount of genes, specifically, mRNA or protein, that code for monoamine oxidase B; and a use thereof in the prevention, alleviation, or treatment of liver disease, obesity, or neurological diseases.
Inventors
IPC Classification
A61K 31/ 7088 A I
A61K 48/ 00 A I
A61P 25/ 28 A I
C12N 15/ 113 A I
WO
2023234675
A1
View →
20231207
EP
4534671
A1
20250409
JP
2025518230
A
20250612
JP
7904925
B2
20260813
KR
20250022712
A
20250217
US
2025340884
A1
View →
20251106
KR
66057/2022
Filed 2022-05-30
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copy
Most orders are placed same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this PCT's details
Quick Facts
- PCT No.
- PCT/KR2023/007377
- Pub. No.
- WO2023234675
- Filed
- May 30, 2023
- Published
- Dec. 7, 2023